To transfer the speed of products from the lab to the market, Ontario Genomics Institute (OGI) management provides early-stage investment funds up to $100k per project as an investment fund. The project must involve genomics, proteomics or associated technologies that are or have been key enabling components and be in the validation phase of research. Areas may include laboratory and medical devices, diagnostics, small-molecule strategies for disease therapy, nutraceuticals, crop or livestock trait improvements, environmental management, high-throughput robotics and complementary technologies such as analysis and information technology (i.e. databases).
To read the full, original article click on this link: Pre-commercialization Business Development Fund (PBDF)
